BioSpace News Archive

Hologic, Inc. announced preliminary revenue results for its first fiscal quarter ended December 30, 2023.

Shanghai Argo Biopharmaceutical Co., Ltd. announced that it has entered into two exclusive license and collaboration agreements with Novartis PHARMA AG.

Accelerate Diagnostics, Inc. announced certain preliminary, unaudited results for the quarter and year ended December 31, 2023.

Akoya Biosciences, Inc., The Spatial Biology Company®, announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2023, and projected year end 2023 cash, cash equivalents, and restricted cash balance, which remain subject to quarter end closing adjustments and are also unaudited.

Affini-T Therapeutics, Inc. announced that Jak Knowles, M.D., Co-founder, President and Chief Executive Officer, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 3:00 p.m. PT.

Curevo Vaccine announced positive data from an 876-patient Phase 2 trial of amezosvatein head-to-head versus Shingrix in participants aged 50 years and older.

Isomorphic Labs, a digital biology company with a mission to redefine drug discovery using the power of artificial intelligence, announced that it has entered into a strategic research collaboration with Eli Lilly and Company.

Vincerx Pharma, Inc. announced promising clinical results from a Phase 1 NIH-sponsored study of enitociclib in combination with venetoclax and prednisone for the treatment of relapsed/refractory lymphoma.

Singular Genomics Systems, Inc. announced instrument shipments and preliminary unaudited revenue for the fourth quarter of 2023.

Dewpoint Therapeutics Inc. announced the filing of multiple patent applications covering novel compounds and their use in the potential treatment of amyotrophic lateral sclerosis.